Literature DB >> 14758102

Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome.

Yves Cottin1, Jean-Pierre Cambou, Jean Marie Casillas, Jean Ferrières, Christelle Cantet, Nicolas Danchin.   

Abstract

PURPOSE: Cardiac rehabilitation after acute coronary syndrome is an important but underused therapeutic intervention. The aim of the French nationwide PREVENIR survey was to improve knowledge on the management of cardiovascular risk factors, especially during cardiac rehabilitation after acute coronary syndrome. The purpose of this study was to specify the characteristics of patients referred to cardiac rehabilitation.
METHODS: The survey was performed in 77 of 501 (15.4%) public or private French coronary care units. All French regions were involved. All the patients admitted to the hospital during January 1998 who survived an acute coronary syndrome were included in the survey. Data on rehabilitation practice were collected from patient medical records, either during an outpatient consultation or from the patient and the general practitioner during the 6-month follow-up period.
RESULTS: Of the 1394 patients included in the study (779 with myocardial infarction and 615 with unstable angina), only 310 (22%) underwent cardiac rehabilitation. Significant differences in patient characteristics were found between the cardiac rehabilitation and non-cardiac rehabilitation groups, respectively, in terms of gender (82% male vs 68%; P <.001), age younger than 65 years (56% vs 39%; P <.001), type of acute coronary syndrome (75% myocardial infarction vs 50%; P <.001), left ventricular ejection fraction less than 35% (6% vs 13%; P <.0004), and prevalence of percutaneous intervention (54% vs 46%; P <.02). Two risk factors were more common in the rehabilitated group: dyslipidemia (52% vs 44%; P <.02) and current smoking (51% vs 37%; P <.0001). In the multivariate analysis, female gender (odds ratio [OR], 0.6; 95% confidence interval [CI], 0.44-0.87) and older age (>75 years vs. <65 years; OR, 0.40; 95% CI, 0.3-0.7) predicted decreased cardiac rehabilitation prescription. Conversely, previous history of dyslipidemia (OR,1.4; 95% CI, 1.04-1.8), post-myocardial infarction (OR, 2.8; 95% CI, 2.13-3.89), and a percutaneous intervention (OR,1.9; 95% CI, 1.3-2.7) predicted increased cardiac rehabilitation prescription. Severe left ventricular impairment (< or =35% vs >50%) was not an independent factor for cardiac rehabilitation prescription. At 6-month follow-up assessment, rehabilitation patients had a lower rate of hypertension (18% vs 27%), elevated low-density lipoprotein cholesterol (54% vs 62%), and continued smoking (34% vs 50%).
CONCLUSIONS: The results of the PREVENIR survey underscore the low level of cardiac rehabilitation prescription in France, and the relative exclusion of women and elderly people. Among the risk factors, dyslipidemia and current smoking are more frequent among rehabilitated patients. These findings may help to modify the strategy for using cardiac rehabilitation after acute coronary syndrome, although it is an effective intervention for secondary prevention.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14758102     DOI: 10.1097/00008483-200401000-00008

Source DB:  PubMed          Journal:  J Cardiopulm Rehabil        ISSN: 0883-9212            Impact factor:   2.081


  13 in total

Review 1.  Global availability of cardiac rehabilitation.

Authors:  Karam Turk-Adawi; Nizal Sarrafzadegan; Sherry L Grace
Journal:  Nat Rev Cardiol       Date:  2014-07-15       Impact factor: 32.419

Review 2.  Narrative review comparing the benefits of and participation in cardiac rehabilitation in high-, middle- and low-income countries.

Authors:  Karam I Turk-Adawi; Sherry L Grace
Journal:  Heart Lung Circ       Date:  2014-11-29       Impact factor: 2.975

Review 3.  Barriers physicians face when referring patients to cardiac rehabilitation: a narrative review.

Authors:  Carol Elsakr; David A Bulger; Sherif Roman; Irene Kirolos; Rami N Khouzam
Journal:  Ann Transl Med       Date:  2019-09

4.  Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study).

Authors:  John N Booth; Emily B Levitan; Todd M Brown; Michael E Farkouh; Monika M Safford; Paul Muntner
Journal:  Am J Cardiol       Date:  2014-04-01       Impact factor: 2.778

5.  The effects of a cardiac rehabilitation program tailored for women on global quality of life: a randomized clinical trial.

Authors:  Theresa M Beckie; Jason W Beckstead
Journal:  J Womens Health (Larchmt)       Date:  2010-09-16       Impact factor: 2.681

6.  Equity of access to cardiac rehabilitation: the role of system factors.

Authors:  Jennifer A Stewart Williams; Julie E Byles; Kerry J Inder
Journal:  Int J Equity Health       Date:  2010-01-21

7.  State-by-state variations in cardiac rehabilitation participation are associated with educational attainment, income, and program availability.

Authors:  Diann E Gaalema; Stephen T Higgins; Donald S Shepard; Jose A Suaya; Patrick D Savage; Philip A Ades
Journal:  J Cardiopulm Rehabil Prev       Date:  2014 Jul-Aug       Impact factor: 2.081

8.  Examining the challenges of recruiting women into a cardiac rehabilitation clinical trial.

Authors:  Theresa M Beckie; Mary Ann Mendonca; Gerald F Fletcher; Douglas D Schocken; Mary E Evans; Steven M Banks
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 Jan-Feb       Impact factor: 2.081

9.  A supportive-educational intervention for heart failure patients in iran: the effect on self-care behaviours.

Authors:  Vahid Zamanzadeh; Leila Valizadeh; A Fuchsia Howard; Fatemeh Jamshidi
Journal:  Nurs Res Pract       Date:  2013-09-22

10.  Home-based cardiac rehabilitation is an attractive alternative to no cardiac rehabilitation for elderly patients with coronary heart disease: results from a randomised clinical trial.

Authors:  Bodil Oerkild; Marianne Frederiksen; Jorgen Fischer Hansen; Eva Prescott
Journal:  BMJ Open       Date:  2012-12-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.